Regeneron (REGN), Sanofi (SNY) Receive FDA Complete Response Letter for Sarilumab BLA as RA Treatment

Regeneron (REGN) Halted, News Pending

Regeneron (NASDAQ: REGN) Halted, News Pending

Sanofi (SNY) Alerts Regeneron (REGN) of FDA Concerns Related to Sarilumab Manufacturing Facility

Regeneron (Nasdaq: REGN) disclosed the following in a U.S. SEC filing on Friday:

Item 8.01 - Other Events.

Regeneron Pharmaceuticals, Inc. (Regeneron or the Company) has been advised by its collaborator Sanofi that manufacturing deficiencies have been raised by the U.S. Food and Drug Administration (the FDA) during a routine Current... More